378 related articles for article (PubMed ID: 22496457)
21. 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells.
Lehtinen L; Vainio P; Wikman H; Reemts J; Hilvo M; Issa R; Pollari S; Brandt B; Oresic M; Pantel K; Kallioniemi O; Iljin K
J Pathol; 2012 Mar; 226(4):674-86. PubMed ID: 22072156
[TBL] [Abstract][Full Text] [Related]
22. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
23. P-cadherin role in normal breast development and cancer.
Albergaria A; Ribeiro AS; Vieira AF; Sousa B; Nobre AR; Seruca R; Schmitt F; Paredes J
Int J Dev Biol; 2011; 55(7-9):811-22. PubMed ID: 22161837
[TBL] [Abstract][Full Text] [Related]
24. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Park CY; Kim DK; Sheen YY
Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
[TBL] [Abstract][Full Text] [Related]
25. Arachidonic acid promotes epithelial-to-mesenchymal-like transition in mammary epithelial cells MCF10A.
Martinez-Orozco R; Navarro-Tito N; Soto-Guzman A; Castro-Sanchez L; Perez Salazar E
Eur J Cell Biol; 2010 Jun; 89(6):476-88. PubMed ID: 20207443
[TBL] [Abstract][Full Text] [Related]
26. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
27. RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness.
Benítez S; Cordero A; Santamaría PG; Redondo-Pedraza J; Rocha AS; Collado-Solé A; Jimenez M; Sanz-Moreno A; Yoldi G; Santos JC; De Benedictis I; Gómez-Aleza C; Da Silva-Álvarez S; Troulé K; Gómez-López G; Alcazar N; Palmero I; Collado M; Serrano M; Gonzalez-Suarez E
Dev Cell; 2021 Jun; 56(12):1727-1741.e7. PubMed ID: 34004159
[TBL] [Abstract][Full Text] [Related]
28. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
29. Linoleic acid induces an EMT-like process in mammary epithelial cells MCF10A.
Espinosa-Neira R; Mejia-Rangel J; Cortes-Reynosa P; Salazar EP
Int J Biochem Cell Biol; 2011 Dec; 43(12):1782-91. PubMed ID: 21945809
[TBL] [Abstract][Full Text] [Related]
30. Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol.
Huang Y; Fernandez SV; Goodwin S; Russo PA; Russo IH; Sutter TR; Russo J
Cancer Res; 2007 Dec; 67(23):11147-57. PubMed ID: 18056439
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional properties of RANKL/RANK in cell differentiation, proliferation and metastasis.
Kukita A; Kukita T
Future Oncol; 2013 Nov; 9(11):1609-22. PubMed ID: 24156322
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells.
Pinkas J; Martin SS; Leder P
Mol Cancer Res; 2004 Oct; 2(10):551-6. PubMed ID: 15498929
[TBL] [Abstract][Full Text] [Related]
33. Role of the RANK/RANKL pathway in breast cancer.
Kiesel L; Kohl A
Maturitas; 2016 Apr; 86():10-6. PubMed ID: 26921922
[TBL] [Abstract][Full Text] [Related]
34. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
[TBL] [Abstract][Full Text] [Related]
35. Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role.
Zhang X; Zhao X; Shao S; Zuo X; Ning Q; Luo M; Gu S; Zhao X
Int J Oncol; 2015 Mar; 46(3):1141-8. PubMed ID: 25544568
[TBL] [Abstract][Full Text] [Related]
36. HAS2 and CD44 in breast tumorigenesis.
Heldin P; Basu K; Kozlova I; Porsch H
Adv Cancer Res; 2014; 123():211-29. PubMed ID: 25081531
[TBL] [Abstract][Full Text] [Related]
37. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
[TBL] [Abstract][Full Text] [Related]
38. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
[TBL] [Abstract][Full Text] [Related]
39. Promotion of epithelial-mesenchymal transition and tumor growth by 17β-estradiol in an ER(+)/HER2(+) cell line derived from human breast epithelial stem cells.
Wang KH; Kao AP; Lin TC; Chang CC; Kuo TC
Biotechnol Appl Biochem; 2012; 59(3):262-7. PubMed ID: 23586837
[TBL] [Abstract][Full Text] [Related]
40. Mammary tumor formation and metastasis evoked by a HER2 splice variant.
Alajati A; Sausgruber N; Aceto N; Duss S; Sarret S; Voshol H; Bonenfant D; Bentires-Alj M
Cancer Res; 2013 Sep; 73(17):5320-7. PubMed ID: 23867476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]